The biosynthesis of sulfur-containing molecules, which play essential roles in cell metabolism, often relies on enzymes that mobilize sulfur from cysteine. The function of such enzyme, L-cysteine desulfidase CyuA, which catalyzes L-cysteine decomposition to pyruvate, ammonia, and hydrogen sulfide, remains incompletely understood. Here, we used phylogenetic, genetic, biochemical, spectroscopic, and structural approaches to connect molecular structure to cellular physiology and evolutionary history and elucidate CyuA’s role in sulfur metabolism. We found that Methanococcales and several other archaeal lineages acquired CyuA via horizontal gene transfer from bacteria. In Methanococcus maripaludis , CyuA (MmCyuA) stimulates growth in sulfide-rich conditions and enables slow growth with cysteine as the sole sulfur source. Crystallographic and biochemical data reveal that MmCyuA binds a [4Fe-4S] cluster coordinated by three conserved cysteines; the fourth ligand is a nonconserved cysteine in the wild-type enzyme but is replaced by glycerol or ethylene glycol in a variant. These results enabled modeling of the enzyme–substrate complex, allowing us to propose a detailed mechanism for L-cysteine desulfuration by CyuA, potentially involving a transient [4Fe-5S] species to transfer sulfur from cysteine to various [4Fe-4S]-dependent tRNA sulfuration enzymes. These findings advance understanding of sulfur activation and trafficking related to biosynthetic pathways leading to sulfur-containing compounds.
Methyl-coenzyme M reductase (MCR) is a crucial enzyme for methanogenesis and harbors several unusual post-translational modifications. Recent studies have identified glutamine C-methyltransferase (QCMT), as a B 12 -dependent radical SAM enzyme responsible for methylating a glutamine residue within the MCR active site. B 12 -dependent radical SAM enzymes have the remarkable ability to alkylate unactivated C
sp
2 - and
Csp
3 -atoms in a stereoselective manner. However, the factors influencing the stereo-selectivity and catalytic properties of this emerging superfamily of enzymes remain poorly understood. In this study, we report the mechanistic, structural, and biochemical investigation of several QCMTs. Our findings reveal significant differences among them, notably in their ability to bind cobalamin. In addition, our data support that Cα H-atom abstraction and methyl transfer are not concerted but rather independent processes that require motion within the enzyme’s active site. We also demonstrate that QCMT can catalyze novel reactions, including the formation of unnatural C -methylated residues, peptide epimerization, reversible H-atom abstraction, and the direct conversion of glycine into d -alanine. Overall, our data are consistent with QCMT being a unique and versatile biocatalyst allowing for the installation of unnatural post-translational modifications and provide a structural and biochemical rationale for the control of the stereochemistry by B 12 -dependent radical SAM enzymes.
Methyl-coenzyme M reductase (MCR) is a crucial enzyme for methanogenesis and harbors several unusual post-translational modifications. Recent studies have identified glutamine C-methyltransferase (QCMT), as a B12-dependent radical SAM enzyme responsible for methylating a glutamine residue within the MCR active site. B12-dependent radical SAM enzymes have the remarkable ability to alkylate unactivated Csp2- and Csp3-atoms in a stereoselective manner. However, the factors influencing the stereo-selectivity and catalytic properties of this emerging superfamily of enzymes remain poorly understood. Here, we report the mechanistic, structural, and biochemical investigation of several QCMTs. Our findings reveal significant differences among them, notably in their ability to bind cobalamin. In addition, our data support that Cα H-atom abstraction and methyl transfer are not concerted but rather independent processes that require motion within the enzyme's active site. We also demonstrate that QCMT catalyzes novel reactions, including the formation of unnatural C-methylated residues, peptide epimerization, reversible H-atom abstraction, and the direct conversion of glycine into D-alanine. Overall, our data are consistent with QCMT being a unique and versatile biocatalyst allowing for the installation of unnatural post-translational modifications and provide a structural and biochemical rationale for the control of the stereochemistry by B12-dependent radical SAM enzymes.
La biosynthèse des centres Fe-S est un processus impliquant un très grand nombre de protéines et la déficience de l’une de ces protéines conduit à des pathologies sévères : anémie, processus neurodégénératif, diabètes, hypertrophie cardiaque et même cancers. Ces centres Fe-S sont des groupements prosthétiques de protéines impliquées dans une multitude de processus redox tels que la production d'ATP, la catalyse enzymatique, la synthèse protéique ou encore la maintenance de l'intégrité du génome. Les stratégies thérapeutiques basées sur le développement de composés capable de mimer la fonction des protéines assurant la synthèse des centres Fe-S sont peu développées en raison du manque d'information sur les mécanismes moléculaires et biochimiques de synthèse de ces cofacteurs métalliques particulièrement versatiles. Le projet de thèse s’est principalement intéressé à l’élucidation du mécanisme de biosynthèse des centres Fe-S par la machinerie ISC et au rôle fonctionnel de la frataxine dans ce processus qui est une protéine centrale dont le défaut d'expression conduit à l'ataxie de Friedreich, une maladie neurodégénérative et cardiaque. En effet, la séquence d’assemblage de ces centres Fe-S était mal défini notamment sur la coordination de l’insertion du fer et du soufre pour former un centre polynucléaire Fe-S. De plus, la nature du produit final de cette machinerie ISC était sujette à débat : [2Fe2S] ou [4Fe4S]. L'objectif principal de ce projet de thèse était de reconstituer in vitro la machinerie d'assemblage des centres Fe-S, eucaryote et procaryote, à partir des protéines purifiées afin de déterminer les bases biochimiques et structurales du processus d'assemblage en utilisant un panel de techniques biochimiques (cinétique d’assemblage, test d’alkylation) et biophysiques (spectroscopies Mössbauer, RMN, RPE, spectrométrie de masse native et dichroïsme circulaire), dans le but de comprendre comment les centres Fe-S sont synthétisés et comment la frataxine régule ce processus.